Introduction
Alcohol dependence (AD) is linked to a wide range of adverse physical, mental, and social effects. In the US, during a one-year period, 17.8 million adults were estimated to meet criteria for an alcohol use disorder (1) . The adverse consequences associated with these disorders resulted in an estimated annual cost of nearly $184.6 billion in the US in 1998 (2) .
AD is a complex and multi-factorial disorder arising from interactions between genetic and environmental risk factors. Evidence from twin, adoption, and family studies shows that AD is genetically influenced, with a heritability of 50-60% (3) . The inherited vulnerability to AD corresponds in part to interindividual differences in pharmacokinetics (i.e., alcohol absorption, distribution, and metabolism) and the pharmacodynamic response to alcohol (4) . This vulnerability arises from the concurrent impact of functional variation at numerous risk genes, in the context of the molecular complexity of the nervous system, leading to considerable genetic heterogeneity (5) . Candidate gene studies have shown that genes conferring either a predisposition to AD or protective effects fall into different classes, including those encoding proteins regulating the metabolism of alcohol (e.g., alcohol or aldehyde dehydrogenase genes (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) ), and those that encode functional receptors or receptor subunits that interact with alcohol or related systems (e.g., GABRA2 (19) (20) (21) (22) ).
Four genes, which encode neural cell adhesion molecule 1 (NCAM1), tetratricopeptide repeat domain 12 (TTC12), ankyrin repeat and kinase domain containing 1 (ANKK1), and the D 2 dopamine receptor (DRD2), occur in a ~542 kilobase (kb) cluster on chromosome 11q (23) . In this gene cluster, DRD2 maps molecularly close to neural cell adhesion molecule 1 (NCAM1), and both are functional candidates for AD risk. ANKK1 and TTC12 map between DRD2 and NCAM1. We recently reported a strong association between a haplotype spanning TTC12 and ANKK1 and nicotine dependence (ND) (23) . All four of these genes may thus now reasonably be considered candidate loci for substance dependence.
The D 2 dopamine receptor gene, DRD2 (OMIM # 126450), encodes a G protein-coupled receptor located on postsynaptic dopaminergic neurons, which plays a central role in rewardmediating mesocorticolimbic pathways (24) . DRD2 has been widely studied as a risk gene for AD and other substance dependence (SD) traits (25) (26) (27) . ANKK1 rs1800497, previously called "DRD2 TaqI 'A'", is one of the most frequently studied polymorphisms in DRD2 genetic studies (28) ; however, the evidence associating this variant with AD, first reported more than 15 years ago (29) , remains ambiguous and controversial. Neville and colleagues (24) determined that the DRD2 TaqI "A" is actually located not within DRD2, but rather within a protein-coding region, exon 8, of the adjacent ANKK1 gene. ANKK1 maps less than 10 kb downstream of DRD2, spans approximately 13 kb, contains 8 exons, and encodes a deduced 765-amino acid protein involved in signal transduction pathways (24) .
NCAM1 is part of the immunoglobulin gene superfamily; it maps about 120 kb downstream of DRD2 (NCBI Build 35.1, http://www.ncbi.nlm.nih.gov/), spans approximately 316 kb, and contains at least 19 exons. Neural cell adhesion molecule (NCAM), the protein encoded by this gene, is involved in various neural functions including mediating adhesion among neurons and between neurons and muscle, structural linkages to extracellular and intracellular proteins, synaptic stability and plasticity, neural development, signal transduction, long term potentiation, neurogenesis, memory consolidation, and learning (30) (31) (32) (33) (34) (35) . Dysregulation of NCAM isoforms in brain may contribute to the pathophysiology of neuropsychiatric disorders (35) , and association of NCAM1 polymorphisms with bipolar disorder was observed in a Japanese population (36) .
Tetratricopeptide repeat domain 12 gene (TTC12) is located between the NCAM1 and ANKK1 genes, spans 58.75 kb (NCBI build 35), and consists of 22 exons, encoding a 705-amino-acid protein with tetratricopeptide repeat (TPR) and armadillo repeat (ARM) domains (37) . Its physiological function is not understood thoroughly, but it appears likely to interact with dopamine pathways.
In this study, we examined the association of AD with variants that map to each of these four genes using a large clinical case-control sample and an independent family sample, in which we genotyped a panel of 43 SNPs that map to this region, including well-known functional variants (23) .
Results

Gene and marker characteristics
The relative location of the four genes and the selected SNPs is shown in Figure 1 . ANKK1 is the smallest gene (~13kb) among the four; the lengths of NCAM1 (~316kb), TTC12 (~58kb) and DRD2 (~65kb) are 25, 4.6, and 5.2 times the length of ANKK1, respectively. The average intermarker distance was 12kb. Linkage disequilibrium (LD) coefficients (D') and haplotype blocks are plotted in Figure 2 for all subjects of the case-control and family samples. Minor allele frequencies (MAF) estimated from the case-control and the founders of family samples were shown in Table 1 .
Single SNP association analysis
Single SNP allelic association screening for susceptibility loci from both samples identified two SNPs in each sample that were nominally significant (see online supplemental Table 1 ), i.e., no longer significant after correction for multiple testing. For the case-control sample, SNP T7, located in intron 7 of TTC12 (p = 0.0095), and SNP D2 in intron 2 of DRD2 (p = 0.030), were nominally significantly associated with AD, when adjusted for age and sex; for the family sample, SNP N8 and SNP N9, located respectively in exon 12 and intron 13 of NCAM1 (p = 0.036 and 0.022, respectively, from FBAT tests without adjusting for age and sex) were nominally significantly associated with AD.
Global haplotype association analysis
We defined "exhaustive search" as a sliding window of three, four or five SNPs in consecutive positional order for construction of haplotypes, and the "starting SNP" in a haplotype as the first SNP in the direction from centromere to telomere, i.e., from NCAM1 to DRD2. We employed an exhaustive search of haplotypic effects using the "haplo.score.slide" function in the Haplo.stats package, and the analogous approach in FBAT. Age and sex were covaried in these tests for the case-control sample. Significant haplotypic effects emerged ( Figure 3A In the completely independent family sample, significant haplotypic associations to AD were replicated in T3-T5, T1-T4, T2-T5 and T1-T5 in TTC12 (p sg = 0.018 to 0.007). One haplotype extending across ANKK1 to DRD2, A7-D3, was also associated (p sg = 0.032) in the family sample.
Also in the family sample, the exhaustive search of haplotypic effects uncovered another associated region, not identified in the case-control sample, around exon 12 of NCAM1 (Figure 3 B). The 3-SNP haplotypes N6-N8, N8-N10, and N9-N11; the 4-SNP haplotypes N6-N9, N8-N11, and N9-N12; and the 5-SNP haplotypes N5-N9, N7-N11, N8-N12, and N9-N13 were all associated with AD (p sg = 0.049 ~ 0.008). The results for all of the global haplotype association analyses are summarized in online supplemental Table 1 .
Specific haplotype association analysis
The associated haplotype sets described above were further investigated, to identify specific risk or protective haplotypic effects. Table 2 lists the specific associated haplotypes. Viewed graphically, these haplotypic variants display a mosaic of nucleotide patterns indicative of positive or negative association to AD. For the family sample, the cluster around exon 12 of NCAM1 had a protective effect shown by nucleotides T-C-A of N8-N10, located in exon 12 to intron 13, spanning 6950 bp. In contrast, nucleotides G-A-A at the same SNP positions, with haplotype frequency ~12% (i.e., approximately half of the haplotype frequency of most of the other associated haplotypes for the family sample, Table 2 ), conveyed a risk effect. It is noteworthy that the "C" allele at SNP N9 appeared in all of the associated protective haplotypes (Table 2) .
For the family sample, the haplotypic risk effect in TTC12 corresponds to nucleotides G-G-A of the haplotype T3-T5 (Table 2) (Table 2 ) (a situation denoted "yin yang haplotypes" (38) i.e., the allele at each corresponding SNP position is different). These associated haplotypes relevant to T4-T5 (mapping to TTC12) shared a common G-A (or T-C, in some haplotypes observed in the casecontrol and family samples) risk motif. There were two additional significant protective haplotypes starting from T7 to T10 and T10 to A3 sharing G-G-C in T8-T10 and C-A-A in T10-A2, located in the upstream portion and extending to exon 2 of ANKK1, and a stand-alone risk haplotype of C-G-C-C-A in T10 to A4 originating from C-A-C in A3-A5 centering on A4 in exon 5 of ANKK1. These three haplotypes all have frequencies around 5%, which is relatively low compared to all the other associated haplotypes, which had frequencies of >10%.
LD comparisons between cases and controls were accomplished by use of LD Contrast Test software. Two regions, one around TTC12 exon 3 (SNPs T2 to T5) and another around ANKK1 exon 2 (SNPs T10 to A3), were identified as differing in the standardized composite LD (both p = 0.000005). The LD difference gradually disappeared as the number of included SNPs was increased. The differences in pairwise LD matrices are displayed by ellipse plots (Figure 4 ) in which the shape of an ellipse indicates the magnitude of LD and the direction shows the sign of the disequilibrium. The more circular shape of an ellipse reflects a low degree of LD, and 45º-oriented ellipses suggest a positive value of LD. This finding from the LD contrast test further supports our association results and provides evidence of selection around TTC12 exon3 and ANKK1 exon2 in affected subjects. Such selection would reflect the presence of a functional variant.
Population stratification was tested using a panel of 37 short tandem repeat (STR) markers that we designed to differentiate major US populations (39) . The average ancestry proportion for EAs was 96.4% in ADs and 95.9% in controls. In the absence of evidence of population stratification in this study sample, it was ruled out as a source of spurious association in the case-control sample. The family-based analyses are not considered subject to stratification artifact.
In summary, a susceptibility region near exon 3 of TTC12 (marked by SNPs T4 and T5) was a significant risk locus that was evident in both the case-control and the family samples. This is the most important risk region, judging by the level of statistical significance. There was an additional region near exon 12 to intron 13 of NCAM1 marked by SNPs N8, N9, and N10 affecting risk or protection against AD for the nucleotides of T-C-A carriers in the family sample.
Another region around exon 2 (SNP A2) and exon 5 (SNP A4) of ANKK1 also affects AD risk but shows relatively low haplotype frequencies (e.g., the haplotype frequency for nucleotides C-G-C-C-A of haplotype T10-A4 is around 7.3% for cases and 3.8% for controls and 5.3% for pooled cases and controls).
Discussion
We present here, in two independent EA samples, strong evidence for association of markers mapped to different locations within a four-gene cluster on chromosome 11q with AD. The key finding of the haplotype association analyses was that exon 3 of TTC12 is, or is close to, a risk locus for AD, and was evident in both samples, where the minimal individual haplotype simulated p = 0.00021. Further, the LD contrast test showed different LD in TTC12 exon 3 between the cases with AD, in contrast to controls, supporting the hypothesis that this region has undergone selection; this is additional independent evidence supporting an association. This is the first study to find association between TTC12 and AD. Although little is known that is specific about its biological action, more is known about the action of its armadillo repeat domain. An armadillo repeat domain can bind to other proteins, with function related to signal transduction, regulation of desmosome assembly (important for cell adhesion), neurogenesis, and post development synaptogenesis. Beta-catenin, a prototypical armadillo domain containing protein, has been implicated as an integral component in the Wnt signaling pathway. Betacatenin and dopamine interact in the Wnt pathway, which has effects on dopamine cell development in the ventral midbrain (40) . Beta-catenin was identified as a possible susceptibility locus for bipolar affective disorder in a recent whole genome association study (41) . In addition, an armadillo repeat gene (ARVCF) is deleted in velocardiofacial syndrome (VCFS) and is a candidate gene for the psychiatric manifestations of that disorder (42) . Thus, there is considerable circumstantial evidence that ties the function of TTC12 to both DRD2 and NCAM1, supporting our speculation that these genes are related functionally.
Alcohol increases synaptic dopamine, which reinforces self-administration. Thus, most prior investigations of this region have focused on DRD2 only, which, because it encodes a dopamine receptor, bears a potential relationship to these phenotypes. We extended our investigation to include the other three genes in this regional cluster in an attempt to provide an explanation for inconsistently-reported associations with DRD2, which seemed unlikely to be explicable on the basis of functional variation at DRD2 alone. In a prior study (which included family-based association tests in two populations -completely non-overlapping with the present study) (23), we found evidence for association of nicotine dependence to markers in a region spanning ANKK1 and TTC12, as noted above. In the present study, the results are consistent with these previously reported results, but the present study has greater power; two different study designs were used; of these, the case-control study had greater power than the family study, and has allowed a more detailed examination of the relationships between variants and haplotypes in this region and AD. A more complicated picture now emerges, with several associated regions that map to at least three of these loci, and perhaps all four. This supports the presence of multiple risk variants, and is consistent with our previous hypothesis that this set of four genes may have related functions, albeit in a way that is not yet understood. showed association to AD but the juncture of DRD2 and ANKK1 only showed global association.
The role of variants in exon 3 of TTC12 for AD
Further, we cannot exclude effects attributable to a DRD2 regulatory element, or elements, that map in these nearby genes.
Comparison of the analyses for the case-control and the family samples
All association analyses for the case-control sample were adjusted for age and sex, while the family-based association analyses using FBAT were not. This is due to a technical limitation of the FBAT software, but additionally, the design renders such correction much less important because of the family-based context. Further, the FBAT approach tends to be conservative statistically. Because of the conservative family-based design and the smaller sample size, the global p-values were not as significant as those obtained in the case-control design.
The findings in the case-control and family samples were similar except that the findings in NCAM1 were exclusive to the family sample for AD. Note that SNP N9, 1911 bp downstream of SNP N8 in exon12 of NCAM1, is located in intron 13, and was found to be associated with bipolar affective disorder in a Japanese sample for a haplotype block centered on this SNP(36); it was also in an associated haplotype block (N8-N9-N10) in the current study. The differences we observed between the case-control and family samples might also originate from heterogeneity between AD samples, ascertainment bias, and differing statistical power.
Our recent work (23) used the same set of markers to map risk variants for nicotine dependence (ND) in two distinct populations (both completely non-overlapping with the present study) in EA and AA subjects by the family-based association method. The results showed relatively weak evidence for association of the flanking DRD2 and NCAM1 markers to ND, but very strong evidence of association of multiple SNPs at TTC12 and ANKK1 in both populations and in the pooled sample, as well as strong evidence for highly significant association of a single haplotype spanning TTC12 and ANKK1 to ND in the pooled sample (p=0.0000001). We concluded that a risk locus for ND, important both in AAs and EAs, maps to a region that spans TTC12 and ANKK1. A limitation of the present study is that we did not have the ND diagnostic information for the current study samples, so we cannot address the issue of the importance of comorbid ND in driving these associations directly.
Conclusions
We conclude that: 1) exon 3 of TTC12 is a risk locus for AD; 2) the region flanking exon 12 of NCAM1 contains protective or risk variants for AD; 3) in view of the finding that a region spanning TTC12 and ANKK1 is a risk locus for nicotine dependence (23), the findings reported here for alcohol dependence underscore the importance of this cluster of genes on chromosome 11q for determining risk of substance dependence. Replication of the findings in other populations by other investigators is necessary to validate these findings, and functional analysis within these regions is warranted.
Materials and Methods
Subject recruitment and assessment
The study protocol was approved by all relevant institutional review boards. All subjects provided written informed consent and were paid for their participation.
Case-control sample
Seven hundred thirty-two European American subjects (EAs) were recruited at either the University of Connecticut Health Center or the VA Connecticut Healthcare System-West Haven campus. Among them, 318 were affected with AD (including 243 males and 75 females; mean age, 40.8 years) and 414 were healthy controls (of whom there were 167 males and 247 females; mean age, 27.9 years). Affected subjects met lifetime DSM-III-R (44) or DSM-IV (45) diagnostic criteria for AD. Healthy controls were recruited by advertisement from the general population, and screened to exclude individuals with major Axis I mental disorders, including alcohol or drug dependence, mood disorders, major anxiety disorders, and psychotic disorders.
They were screened using the Structured Clinical Interview for DSM-III-R (SCID-III-R) or DSM-IV (SCID-IV), or the Computerized Diagnostic Interview Schedule for DSM-III-R (C-DIS-R). Overall, the control sample was younger and more likely to be female than the patient sample (Table 3-1).
Family Sample
Four hundred eighty-eight EAs from 143 nuclear families were recruited at the same centers, with 136 families assessed using the SCID and seven by the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA), as described elsewhere (46, 47) . Among them, there were 257 parents and 231 siblings; average family size was 3.4 members. The average age of probands was 35.0 years, of AD-affected siblings, 36.1 years, of AD-unaffected siblings, 33.5 years, and of parents, 62.5 years (Table 3-2) .
SNP Selection
We selected SNPs based on prior published association reports, information content, minor allele frequency, functional potential, LD structure, and validation evidence (23) . NCAM1 and DRD2
were targeted initially; ANKK1 was added as it was reported to be adjacent to the 3' end of DRD2, and TTC12 was added to complete the survey of genes mapping from NCAM1 to DRD2.
As shown in Table 1 , 43 SNPs were selected: 17 mapped to NCAM1 (designated N1-N17), 7 to TTC12 (T3-T9), 7 to ANKK1 (A1-A7), and 4 to DRD2 (D1-D4); 8 SNPs were intergenic.
Marker Genotyping
SNPs were genotyped as described previously (23) . Genotyping failure rate for the 43 selected SNPs was 4.2% for the family and 6.4% for the case-control samples. In addition, 37 ancestry informative markers (AIMs) described by Yang et al. (39) were genotyped in all case and control subjects for population admixture analysis.
Family genotype data were error-checked via PedCheck (48) 
Statistical Analysis Linkage Disequilibrium, Haplotype Blocks and Tagging SNPs
Linkage disequilibrium (LD), common haplotype patterns, and allele frequencies were estimated using the software program Haploview 3.32 (http://www.broad.mit.edu/mpg/haploview/) (50).
The LD plot summarizes the standardized LD coefficients, D'. Haplotype blocks were defined according to the criteria of Gabriel et al (51) . Tagging SNPs (tSNPs) were also identified to restrict haplotype analysis in the subsequent association tests and reduce the risk of type 1 error.
We applied Haploview for "aggressive" tagging with 2-or 3-marker haplotypes having pairwise correlation coefficient >0.8. Conformance with HWE expectations was ascertained separately for cases and controls using an exact test in Haploview.
Association Analysis for the Case-Control Design
Single-marker allelic association with AD was screened via a generalized linear model (GLM in R) adjusting for sex and age covariates, and coding genotypes for genotypic additive effects.
Haplotype-based association analysis was implemented via the Haplo.stats Package to circumvent the cumulative Type I error rates that would otherwise result from multiple testing.
The significance level of the haplotype-specific tests within each haplotype set was adjusted by
Bonferroni correction, i.e., the conventional α = 0.05 was divided by the number of major haplotypes with frequency greater than 5.0%.
LD Contrast Test
For true risk loci, LD is generally stronger among cases than controls due to shared disease alleles and haplotypes in a region of genetic association and the effects of selection (53) . The LD contrast test, proposed by Zaykin et al. (54) , was used to compare the standardized composite LD measures between cases and controls via a composite disequilibrium approach without HWE assumption. The permutation parameter was set at 200,000 iterations.
Population Structure Analysis
We used the program Structure 2.1 (55) based on the genotype data for the 37 ancestry informative markers (39, 56, 57) to assess population stratification in the case and control subjects by estimating the ancestry proportion for each EA subject. Two hundred sixty-six African American (AA) subjects (previously ascertained and genotyped) were included in each STRUCTURE run to set AA ancestral allele frequencies, thereby increasing the accuracy when inferring admixture. Simulation parameters were set to 100,000 burn-ins followed by 100,000
iterations, and K was set to 2.
Association Analysis for the Family Design
Allelic association of individual SNPs was examined using the family-based association test (FBAT) method (58, 59) (http://www.biostat.harvard.edu/~fbat/), assuming an additive genetic model under the null hypothesis of no linkage and no association, biallelic mode, minimum number of informative families of 20 for each analysis, and offset of zero. Haplotypic association was also calculated by FBAT with the "hbat" command, with an assumption of a biallelic mode for haplotype-specific association and multi-allelic mode for global association, testing all haplotypes as a whole. Under the null hypothesis of no linkage and no association, all p-values derived from "hbat" in this study were computed using a permutation test (100,000 iterations).
The significance level of haplotype-specific tests was adjusted using a Bonferroni correction (i.e., division by the number of major haplotypes with frequency greater than 5.0%) and ranged from 0.01 ~ 0.00625. N9  N10  N11  N12  N13  T1  T2  T3  T4  T5  T6  T7  T8  T9  T10  A1  A2  A3  A4  A5  A6 Hap-freq 
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